Navigation Links
FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research
Date:4/18/2008

fficacious against ovarian cancer tumors, is non-toxic and is a viable pharmacological candidate for anti-cancer therapy.

About FASgen, Inc.: FASgen, Inc. is a drug development company founded in 2000 by four distinguished Johns Hopkins researchers to create new therapeutic products based on the selective inhibition of fatty acid biosynthesis. The Company has the exclusive license from Johns Hopkins to more than 15 years of research in the field, which research continues under a sponsored research agreement with the University.

The Company have has designed and synthesized many compounds that selectively inhibit fatty acid biosynthesis. One group of these compounds holds great promise for new highly specific therapeutics for cancer and the lead compound, FAS31, has demonstrated remarkable efficacy in the reduction in size of tumors in eight different xenograft models, and is in final preparation for starting clinical trials. Additional compounds have the potential of specific therapeutics for obesity and related metabolic disorder. A final group of compounds have the potential of specific therapeutics for TB, including multiple drug resistant TB (MDR-TB) and latent TB infections that

affect one third of the world's population. For more information, visit FASgen's website at http://www.fasgen.com


'/>"/>
SOURCE FASgen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anthera Presents Data on Varespladib at ATVB Meeting
2. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
3. ProMetic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
4. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
5. Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR
6. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
7. SGX Presents Preclinical MET Data at AACR
8. ARIUS presents new findings for anti-cancer antibody programs at AACR
9. Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses
10. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
11. Genetic Engineering and Biotechnology News (GEN) Presents Exclusive Podcast with Robert Langer, Ph.D. on New Polymeric Drug Delivery Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
(Date:2/27/2015)... South San Francisco, CA (PRWEB) February 27, 2015 ... it is joining forces on February 28 with patients ... globally to raise awareness for Rare Disease Day®. ... of rare diseases and calling attention to the special ... support community around them. , “Cytokinetics is proud to ...
(Date:2/27/2015)... PureTech , a science and technology R&D company focused  ... in the healthcare sector, announced today the appointment of ... the Board of Directors of Sanofi, to its Board ... pleasure to know Chris for many years and I ... more closely now," said Dr. Robert Langer , ...
(Date:2/26/2015)... Feb. 26, 2015 On behalf of biotech ... companies, Wilentz, Goldman & Spitzer, P.A. (Wilentz) ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... denying motions for judgment notwithstanding the verdict, a new ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... Novavax, Inc. (Nasdaq: NVAX ) announced today that Stanley ... and finance committees, replacing board chairman John Lambert on the ... from the board. Mr. Erck has previously served as ... the Novavax board in June 2009. , John Lambert stated: ...
... 1 As conference exhibitor and poster presenter, InVitria ... -- Zap-CHO and Optiferrin. These products add to InVitria,s ... Ingredients for Better Media" promotion at BPI ,09. ... the cell culture media and biomanufacturing industry and will ...
... ... Oragene•DNA product is being used by a team of international researchers to further investigate a ... soil derived from volcanic rock in tropical Africa, Central America and northwest India. , ... (PRWEB) October 1, 2009 -- ...
Cached Biology Technology:Novavax Announces Board of Director Changes 2Novavax Announces Board of Director Changes 3InVitria's Better Ingredients for Better Media to be Showcased at BPI '09 2Researchers Use Oragene●DNA to Find Genetic Link to Neglected Tropical Disease 2Researchers Use Oragene●DNA to Find Genetic Link to Neglected Tropical Disease 3
(Date:2/5/2015)... , Feb. 3, 2015 Despite a ... from industries such as consumer electronics, automotive, storage ... surface mount technology (SMT) screen printers. Innovations in ... control will push the adoption curve up. Meanwhile, ... steady as glue dispensers are indispensable in the ...
(Date:1/22/2015)... TORONTO , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the ... announced the launch of its new website design. ... in its infancy", says Peter O,Neill , founder and ... ever, the industry needs involvement from the key players on ...
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... tobacco smoke that clings to virtually all surfaces long ... common indoor air pollutant nitrous acid to produce dangerous ... a multi-institutional study led by researchers with the Lawrence ... tobacco releases nicotine in the form of a vapor ...
... age is linked to a significantly elevated risk of having ... to an exhaustive study of all births in California during ... age is associated with elevated autism risk only when the ... study found. Published online today in the February issue ...
... the National Cancer Institute (NCI) have found that the prevalence ... women without a personal history of breast cancer is very ... breast cancer in women who are at increased risk for ... the February issue of Cancer Epidemiology, Biomarkers & Prevention ...
Cached Biology News:Study reveals new details on the dangers of third-hand smoke 2Study reveals new details on the dangers of third-hand smoke 3Study reveals new details on the dangers of third-hand smoke 4UC Davis study confirms link between advanced maternal age and autism 2UC Davis study confirms link between advanced maternal age and autism 3UC Davis study confirms link between advanced maternal age and autism 4Few women take tamoxifen to prevent breast cancer 2
Similar to proteasome (prosome, macropain) 26S subunit, ATPase, 1 Antigen: Recombinant Protein...
RABBIT ANTI AMPHOTERIN...
See product name for description....
5,6 Carboxyfluorescein is conjugated to BSA (bovine serum albumin) protein through amide bonds....
Biology Products: